Stifel Financial
ALDX icon

Stifel Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Stifel Financial’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,935
Closed -$85.9K – 3463
2025
Q1 		$85.9K Buy
14,935
+179
+1% +$1.06K ﹤0.01% 3305
2024
Q4 		$73.6K Sell
14,756
-1,352
-8% -$6.94K ﹤0.01% 3284
2024
Q3 		$86.8K Buy
16,108
+591
+4% +$2.81K ﹤0.01% 3260
2024
Q2 		$51.4K Buy
+15,517
New +$60.8K ﹤0.01% 3278
2024
Q1 		– Sell
-13,026
Closed -$45.7K – 3340
2023
Q4 		$45.7K Sell
13,026
-12,297
-49% -$37.9K ﹤0.01% 3230
2023
Q3 		$169K Sell
25,323
-13,494
-35% -$100K ﹤0.01% 3030
2023
Q2 		$326K Buy
38,817
+11,240
+41% +$111K ﹤0.01% 2773
2023
Q1 		$274K Buy
27,577
+12,649
+85% +$89.4K ﹤0.01% 2873
2022
Q4 		$104K Sell
14,928
-1,000
-6% -$5.72K ﹤0.01% 3128
2022
Q3 		$85K Sell
15,928
-3,535
-18% -$21.2K ﹤0.01% 3129
2022
Q2 		$78K Sell
19,463
-5,279
-21% -$18.2K ﹤0.01% 3187
2022
Q1 		$110K Sell
24,742
-9,835
-28% -$39.2K ﹤0.01% 3247
2021
Q4 		$138K Sell
34,577
-34,211
-50% -$261K ﹤0.01% 3222
2021
Q3 		$604K Buy
68,788
+12,991
+23% +$119K ﹤0.01% 2464
2021
Q2 		$632K Sell
55,797
-10,394
-16% -$125K ﹤0.01% 2439
2021
Q1 		$786K Sell
66,191
-25,010
-27% -$288K ﹤0.01% 2159
2020
Q4 		$626K Sell
91,201
-4,830
-5% -$33.9K ﹤0.01% 2172
2020
Q3 		$712K Sell
96,031
-18,342
-16% -$118K ﹤0.01% 1864
2020
Q2 		$477K Buy
114,373
+45,163
+65% +$165K ﹤0.01% 2073
2020
Q1 		$168K Sell
69,210
-10,126
-13% -$45.5K ﹤0.01% 2485
2019
Q4 		$461K Buy
79,336
+53,236
+204% +$307K ﹤0.01% 2308
2019
Q3 		$137K Sell
26,100
-25,449
-49% -$137K ﹤0.01% 2725
2019
Q2 		$310K Buy
51,549
+35,030
+212% +$264K ﹤0.01% 2481
2019
Q1 		$152K Buy
16,519
+5,765
+54% +$49K ﹤0.01% 2639
2018
Q4 		$88K Sell
10,754
-3,200
-23% -$32.8K ﹤0.01% 2575
2018
Q3 		$193K Buy
13,954
+3,437
+33% +$27.9K ﹤0.01% 2591
2018
Q2 		$85K Buy
10,517
+150
+1% +$1.2K ﹤0.01% 2646
2018
Q1 		$79K Buy
+10,367
New +$78.7K ﹤0.01% 2586

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial's ALDX Position: Q2 2025 in Review

Stifel Financial sold out of Aldeyra Therapeutics (ALDX) in Q2 2025, closing a stake of 14,935 shares — an estimated $85.9K sold.

Stifel Financial first reported a position in ALDX in Q1 2018 and held it in 28 quarters. The position peaked at $786K in Q1 2021. 121 funds tracked by Wall St. Rank hold ALDX as of Q2 2025.

  • Stifel Financial reported no remaining Aldeyra Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Stifel Financial sold 14,935 Aldeyra Therapeutics shares in Q2 2025, an estimated $85.9K.
  • Stifel Financial first reported a position in Aldeyra Therapeutics in Q1 2018 and held it in 28 quarters.
  • Stifel Financial's Aldeyra Therapeutics position peaked at $786K in Q1 2021.
  • 121 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2025.

Based on Stifel Financial's 13F filing for Q2 2025, filed 14 Aug 2025.